Iranian Journal of Psychiatry and Behavioral Sciences

Published by: Kowsar

The Relationship Between Obsessive-Compulsive Symptoms and Glycemic Control in Patients with Diabetes

Narges Shams Alizadeh 1 , Azad Maroufi 1 , * , Shima Rostami 2 and Ebrahim Ghaderi 3
Authors Information
1 Neurosciences Research Center, Department of Psychiatry, Kurdistan University of Medical Sciences, Sanandaj, IR Iran
2 Department of Psychiatry, Kurdistan University of Medical Sciences, Sanandaj, IR Iran
3 Social Determinants of Health, Research Center, Kurdistan University of Medical Sciences, Sanandaj, IR Iran
Article information
  • Iranian Journal of Psychiatry and Behavioral Sciences: September 2018, 12 (3); e11611
  • Published Online: July 22, 2018
  • Article Type: Original Article
  • Received: April 6, 2017
  • Revised: June 10, 2017
  • Accepted: November 30, 2017
  • DOI: 10.5812/ijpbs.11611

To Cite: Shams Alizadeh N, Maroufi A, Rostami S, Ghaderi E. The Relationship Between Obsessive-Compulsive Symptoms and Glycemic Control in Patients with Diabetes, Iran J Psychiatry Behav Sci. 2018 ; 12(3):e11611. doi: 10.5812/ijpbs.11611.

Copyright © 2018, Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Materials and Methods
4. Results
5. Discussion
  • 1. Zimmet PZ, Alberti KGMM. Epidemiology of Diabetes—Status of a Pandemic and Issues Around Metabolic Surgery. Diabetes Care. 2016;39(6):878-83. doi: 10.2337/dc16-0273.
  • 2. Mundet X, Pou A, Piquer N, Sanmartin MIF, Tarruella M, Gimbert R, et al. Prevalence and incidence of chronic complications and mortality in a cohort of type 2 diabetic patients in Spain. Prim Care Diabetes. 2008;2(3):135-40. doi: 10.1016/j.pcd.2008.05.001.
  • 3. Song SH, Hardisty CA. Type 2 diabetes mellitus: a high-risk condition for cardiovascular disease irrespective of the different degrees of obesity. Qjm. 2008;101(11):875-9. doi: 10.1093/qjmed/hcn109.
  • 4. Zimmet PZ, Magliano DJ, Herman WH, Shaw JE. Diabetes: a 21st century challenge. Lancet Diabetes Endocrinol. 2014;2(1):56-64. doi: 10.1016/S2213-8587(13)70112-8. [PubMed: 24622669].
  • 5. Tuomi T, Santoro N, Caprio S, Cai M, Weng J, Groop L. The many faces of diabetes: a disease with increasing heterogeneity. Lancet. 2014;383(9922):1084-94. doi: 10.1016/s0140-6736(13)62219-9.
  • 6. Anderson RJ, Freedland KE, Clouse RE, Lustman PJ. The prevalence of comorbid depression in adults with diabetes: a meta-analysis. Diabetes care. 2006;24(6):1069-78. doi: 10.1111/j.1464-5491.2006.01943.x.
  • 7. Chen L, Magliano DJ, Zimmet PZ. The worldwide epidemiology of type 2 diabetes mellitus—present and future perspectives. Nat Rev Endocrinol. 2011;8(4):228-36. doi: 10.1038/nrendo.2011.183.
  • 8. Lustman PJ, Anderson RJ, Freedland KE, de Groot M, Carney RM, Clouse RE. Depression and poor glycemic control: a meta-analytic review of the literature. Diabetes Care. 2000;23(7):934-42. [PubMed: 10895843].
  • 9. Trief PM, Grant W, Elbert K, Weinstock RS. Family environment, glycemic control, and the psychosocial adaptation of adults with diabetes. Diabetes Care. 1998;21(2):241-5. [PubMed: 9539989].
  • 10. Lustman PJ, Griffith LS, Clouse RE, Freedland KE, Eisen SA, Rubin EH, et al. Effects of nortriptyline on depression and glycemic control in diabetes: results of a double-blind, placebo-controlled trial. Psychosom Med. 1997;59(3):241-50. [PubMed: 9178335].
  • 11. Lustman PJ, Griffith LS, Freedland KE, Kissel SS, Clouse RE. Cognitive behavior therapy for depression in type 2 diabetes mellitus. A randomized, controlled trial. Ann Intern Med. 1998;129(8):613-21. [PubMed: 9786808].
  • 12. Smith KJ, Beland M, Clyde M, Gariepy G, Page V, Badawi G, et al. Association of diabetes with anxiety: A systematic review and meta-analysis. J Psychosom Res. 2013;74(2):89-99. doi: 10.1016/j.jpsychores.2012.11.013.
  • 13. Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE. Lifetime Prevalence and Age-of-Onset Distributions of DSM-IV Disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005;62(6):593. doi: 10.1001/archpsyc.62.6.593.
  • 14. McEvoy PM, Grove R, Slade T. Epidemiology of Anxiety Disorders in the Australian General Population: Findings of the 2007 Australian National Survey of Mental Health and Wellbeing. Aust N Z J Psychiatry. 2011;45(11):957-67. doi: 10.3109/00048674.2011.624083.
  • 15. Wittchen HU, Fehm L. Epidemiology, patterns of comorbidity, and associated disabilities of social phobia. Psychiatr Clin North Am. 2001;24(4):617-41. [PubMed: 11723624].
  • 16. Leray E, Camara A, Drapier D, Riou F, Bougeant N, Pelissolo A, et al. Prevalence, characteristics and comorbidities of anxiety disorders in France: Results from the “Mental Health in General Population” Survey (MHGP). Eur Psychiatry. 2011;26(6):339-45. doi: 10.1016/j.eurpsy.2009.12.001.
  • 17. Lustman PJ, Griffith LS, Clouse RE, Cryer PE. Psychiatric illness in diabetes mellitus. Relationship to symptoms and glucose control. J Nerv Ment Dis. 1986;174(12):736-42. [PubMed: 3783141].
  • 18. Collins MM, Corcoran P, Perry IJ. Anxiety and depression symptoms in patients with diabetes. Diabet Med. 2009;26(2):153-61. doi: 10.1111/j.1464-5491.2008.02648.x.
  • 19. Lloyd CE, Dyer PH, Barnett AH. Prevalence of symptoms of depression and anxiety in a diabetes clinic population. Diabet Med. 2000;17(3):198-202. [PubMed: 10784223].
  • 20. Ludman E, Katon W, Russo J, Simon G, Von Korff M, Lin E, et al. Panic episodes among patients with diabetes. Gen Hosp Psychiatry. 2006;28(6):475-81. doi: 10.1016/j.genhosppsych.2006.08.004.
  • 21. Gore M, Brandenburg NA, Dukes E, Hoffman DL, Tai KS, Stacey B. Pain Severity in Diabetic Peripheral Neuropathy is Associated with Patient Functioning, Symptom Levels of Anxiety and Depression, and Sleep. J Pain Symptom Manage. 2005;30(4):374-85. doi: 10.1016/j.jpainsymman.2005.04.009.
  • 22. Chyun DA, Melkus GD, Katten DM, Price WJ, Davey JA, Grey N, et al. The Association of Psychological Factors, Physical Activity, Neuropathy, and Quality of Life in Type 2 Diabetes. Biol Res Nurs. 2006;7(4):279-88. doi: 10.1177/1099800405285748.
  • 23. Trento M, Raballo M, Trevisan M, Sicuro J, Passera P, Cirio L, et al. A cross-sectional survey of depression, anxiety, and cognitive function in patients with type 2 diabetes. Acta Diabetol. 2011;49(3):199-203. doi: 10.1007/s00592-011-0275-z.
  • 24. Balhara YPS, Sagar R. Correlates of anxiety and depression among patients with type 2 diabetes mellitus. Indian J Endocrinol Metab. 2011;15(5):50. doi: 10.4103/2230-8210.83057.
  • 25. Kontoangelos K, Raptis AE, Papageorgiou CC, Papadimitriou GN, Rabavilas AD, Dimitriadis G, et al. The association of the metabolic profile in diabetes mellitus type 2 patients with obsessive-compulsive symptomatology and depressive symptomatology: New insights. Int J Psychiatry Clin Pract. 2012;17(1):48-55. doi: 10.3109/13651501.2012.697563.
  • 26. Kontoangelos K, Raptis AE, Papageorgiou CC, Tsiotra PC, Papadimitriou GN, Rabavilas AD, et al. Oxytocin and Psychological Factors Affecting Type 2 Diabetes Mellitus. Exp Diabetes Res. 2012;2012:1-7. doi: 10.1155/2012/560864.
  • 27. Kruse J, Schmitz N, Thefeld W, German National Health I, Examination S. On the association between diabetes and mental disorders in a community sample: results from the German National Health Interview and Examination Survey. Diabetes Care. 2003;26(6):1841-6. [PubMed: 12766120].
  • 28. Goodman WK, Price LH, Rasmussen SA, Mazure C, Fleischmann RL, Hill CL, et al. The Yale-Brown Obsessive Compulsive Scale. I. Development, use, and reliability. Arch Gen Psychiatry. 1989;46(11):1006-11. [PubMed: 2684084].
  • 29. Esfahani SR, Motaghipour Y, Kamkari K, Zahiredin A, Janbozorgi M. [Reliability and Validity of the Persian Version of the Yale-Brown Obsessive-Compulsive Scale]. IJPCP. 2012;17(4):297-303. Persian.
  • 30. Vandad Sharifi M, Hajebi A, Radgoodarzi R. Twelve-month prevalence and correlates of psychiatric disorders in Iran: the Iranian Mental Health Survey, 2011. Arch Iran Med. 2015;18(2):76.
  • 31. Kettl PA, Marks IM. Neurological factors in obsessive compulsive disorder. Two case reports and a review of the literature. Br J Psychiatry. 1986;149:315-9. [PubMed: 3779297].
  • 32. Lloyd CE, Brown FJ. Depression and diabetes. Curr Womens Health Rep. 2002;2(3):188-93. [PubMed: 12099194].
  • 33. Veldhuis J, Dieleman JP, Wohlfarth T, Storosum JG, van Den Brink W, Sturkenboom MCJM, et al. Incidence and prevalence of “diagnosed OCD” in a primary care, treatment seeking, population. Int J Psychiatry Clin Pract. 2011;16(2):85-92. doi: 10.3109/13651501.2011.617454.
  • 34. Lochner C, Stein DJ. Gender in obsessive-compulsive disorder and obsessive-compulsive spectrum disorders. Arch Womens Ment Health. 2001;4(1):19-26. doi: 10.1007/s007370170004.
  • 35. Castle DJ, Groves A. The internal and external boundaries of obsessive–compulsive disorder. Aust NZ J Psych. 2000;34(2):249-55.
  • 36. Das SK, Elbein SC. The search for type 2 diabetes susceptibility loci: the chromosome 1q story. Curr Diab Rep. 2007;7(2):154-64. [PubMed: 17425920].
  • 37. Shugart YY, Samuels J, Willour VL, Grados MA, Greenberg BD, Knowles JA, et al. Genomewide linkage scan for obsessive-compulsive disorder: evidence for susceptibility loci on chromosomes 3q, 7p, 1q, 15q and 6q. Mol Psychiatry. 2006;11(8):763-70. doi: 10.1038/
  • 38. Engum A. The role of depression and anxiety in onset of diabetes in a large population-based study. J Psychosom Res. 2007;62(1):31-8. doi: 10.1016/j.jpsychores.2006.07.009.
  • 39. Agyemang C, Goosen S, Anujuo K, Ogedegbe G. Relationship between post-traumatic stress disorder and diabetes among 105 180 asylum seekers in the Netherlands. Eur J Public Health. 2011;22(5):658-62. doi: 10.1093/eurpub/ckr138.
  • 40. Boyko EJ, Jacobson IG, Smith B, Ryan MAK, Hooper TI, Amoroso PJ, et al. Risk of Diabetes in U.S. Military Service Members in Relation to Combat Deployment and Mental Health. Diabetes Care. 2010;33(8):1771-7. doi: 10.2337/dc10-0296.
  • 41. Kontoangelos K, Papageorgiou CC, Raptis AE, Tsiotra P, Lambadiari V, Papadimitriou GN, et al. Homocysteine, Cortisol, Diabetes Mellitus, and Psychopathology. J Diabetes Res. 2015;2015:1-10. doi: 10.1155/2015/354923.
  • 42. Atmaca M, Tezcan E, Kuloglu M, Kirtas O, Ustundag B. Serum folate and homocysteine levels in patients with obsessive-compulsive disorder. Psychiatry Clin Neurosci. 2005;59(5):616-20. doi: 10.1111/j.1440-1819.2005.01425.x. [PubMed: 16194269].
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments